ABIONYX Pharma SA (FRA:609)

ABIONYX Pharma Revenue

ABIONYX Pharma had revenue of 2.12M EUR in the half year ending June 30, 2025, a decrease of -0.42%. This brings the company's revenue in the last twelve months to 4.33M, down -10.91% year-over-year. In the year 2024, ABIONYX Pharma had annual revenue of 4.55M, down -1.92%.

• Revenue (ttm): 4.33M
• Revenue Growth: -10.91%
• P/S Ratio: 32.22
• Revenue / Employee: 84.82K
• Employees: 51
• Market Cap: 139.40M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.55M	-89.00K	-1.92%
Dec 31, 2023	4.64M	-612.00K	-11.65%
Dec 31, 2022	5.25M	4.58M	678.07%
Dec 31, 2021	675.00K	-	-
Dec 31, 2020	-	-	-